Trust Company of Vermont’s Inogen INGN Stock Holding History

Trust Company of Vermont’s Portfolio INGN Stock Details INGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-130	Closed	-$24K	–	1080
2018 Q2	$24K	Buy	+130	New	+$21.6K	﹤0.01%	662

Other funds holding INGN

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Trust Company of Vermont's INGN Position: Q3 2018 in Review

Trust Company of Vermont sold out of Inogen (INGN) in Q3 2018, closing a stake of 130 shares — an estimated $24K sold.

Trust Company of Vermont first reported a position in INGN in Q2 2018 and held it in 1 quarter. The position peaked at $24K in Q2 2018. 281 funds tracked by Wall St. Rank hold INGN as of Q3 2018.

Trust Company of Vermont reported no remaining Inogen position as of Q3 2018 after selling out during the quarter.
Trust Company of Vermont sold 130 Inogen shares in Q3 2018, an estimated $24K.
Trust Company of Vermont first reported a position in Inogen in Q2 2018 and held it in 1 quarter.
Trust Company of Vermont's Inogen position peaked at $24K in Q2 2018.
281 funds tracked by Wall St. Rank held Inogen as of Q3 2018.

Based on Trust Company of Vermont's 13F filing for Q3 2018, filed 26 Oct 2018.